Next Steps in Heart Failure: The Changing Paradigms in Therapy to the Unmet Needs

Published: 26 October 2022

  • Views:

    Views Icon 51778
  • Likes:

    Heart Icon 7

Overview

During this broadcast, "Next Steps in Heart Failure: The Changing Paradigms in Therapy to the Unmet Needs", Radcliffe Medical Education brings together a globally-renowned European and American faculty to participate in a roundtable discussion. The aim: to provide both a reflection on the HF landscape following published data at congress and to examine what future developments can be expected at forthcoming events via lively discussion and data presentations.

 

Dr Javed Butler (University of Mississippi Medical Center, US) leads proceedings, and is joined by Dr Clyde Yancy (Northwestern University Feinberg School of Medicine, US), Prof Faiez Zannad (Academic Hospital (CHU), Nancy, FR), and Prof Christiane Angermann (University Hospital of Würzburg, Würzburg, DE) for an insightful presentation and a discussion. 

 

 

This programme is supported by an educational grant from the Boehringer Ingelheim ​and Lilly Alliance.

Upon participation in the roundtable discussion physicians will be able to:

  • Recall the utility of EF in heart failure treatment, patient selection and treatment response
  • Identify alternative measures to EF for the purposes HF severity and therapeutic efficacy
  • Incorporate quality of life measures for assessing therapeutic efficacy in HF
  • Recall outcomes from heart failure trials from recent congress and publications and their impact on practice

This programme is intended to educate:

  • Global Heart Failure Physicians
  • General Cardiologists

More from this programme

Part 1

How Is the Landscape of HF Changing?

Dr Javed Butler introduces the programme and expands on three prevailing topics that have a crucial impact on the current HF field.

Part 2

A Changing Paradigm in the Progression of HF Therapy Initiation

Prof Christiane Angermann explores the progression of HF therapy initiation, focusing on early vs late treatment. She looks at mortality rate after hospitalisation, what are the main reasons for hospitalisation, how outcomes after acute cardiac decompensation have changed with the new paradigm. Prof Angermann looks at different trial results.

Part 3

Roundtable Discussion

In this roundtable discussion the faculty discuss about early treatment and what it means.

Part 4

An ESC 2022 Update: Relevant New Medical Data

Prof Faiez Zannad, in his presentation, looks at the new data that was discussed at ESC Congress 2022. In particular he focuses on the data from the DELIVER and EMPEROR trials and discusses the utility of Ejection Fraction.

Part 5

Applying the Guidelines in Clinical Practice

Dr Clyde Yancy presents the new Guidelines recently released by international health organisations such as the AHA, ACC, HFSA and ESC and how these guidelines can be used in daily clinical practice.

Part 6

Roundtable Discussion: QOL, Implementation in Practice and Future Trials

In this final roundtable discussion the faculty exchange insights and examine the issues related to quality of life.

Faculty Biographies

Faiez Zannad

Faiez Zannad

Professor of Therapeutics and Cardiology, Head of CIC

Dr Faiez Zannad is Professor of Therapeutics & Cardiology and Head of the Division of Heart Failure, Hypertension and Preventive Cardiology for the department of Cardiovascular Disease of the Academic Hospital (CHU) in Nancy and the Director of the Clinical Investigation Centre (Inserm-CHU).

Dr Zannad is currently the Chairman of the ESC Working group on Pharmacology and Drug Therapy as well as a Boardmember of the ESC Heart Failure Association. He is Past-President of the French Society of Hypertension. 

Dr Zannad is Co-Editor-in-Chief for Fundamental and Clinical Pharmacology, the official journal of the European Pharmacology Societies Federation (EUPHAR). He chairs and organises annual international meetings on CardioVascular Clinical Trials (CVCT) and on Biomarkers in Heart Failure.

View full profile